We use cookies to personalise the web experience for you. By using www.helgilibrary.com, you agree to our use of cookies.
Some cookies are also used by Google Analytics, which anonymously tracks visitors and helps us to analyse how users use our website. Read more

Novartis Czech Republic

Pharmaceutical > Czech Republic > Novartis Czech Republic
Change Company
Novartis Czech Republic

Buy all financials of Novartis Czech Republic

from $199 /month

Buy annual subscriptions for all our products.

summary Unit
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Gross Profit CZK mil
EBIT CZK mil
Net Profit CZK mil
ROE %
EBIT Margin %
Net Margin %
Employees
                      3,962 3,930 4,056 4,686 5,393    
                      405 435 500 710 776    
                      56.7 64.0 62.4 97.6 111    
                      41.7 50.0 52.3 82.2 82.7    
                      19.2% 18.9% 16.5% 21.6% 17.8%    
                      1.43% 1.63% 1.54% 2.08% 2.05%    
                      1.05% 1.27% 1.29% 1.75% 1.53%    
                      248 255 267 276 327    

balance sheet

                      1,401 1,514 1,507 1,646 1,911    
                      12.0 23.4 34.3 34.3 55.3    
                      1,383 1,487 1,469 1,611 1,853    
                      238 292 340 423 505    
                      1,163 1,222 1,167 1,224 1,406    
                      0.000 0.000 0.000 0.000 0.000    
                      1,154 1,205 1,147 1,203 1,380    
                      3.22 0.696 -0.064 0.826 -0.015    
                      83.3% 16.7% -1.34% 22.0% -0.390%    
...                     2.97% 10.8% 36.9% 17.3% 12.1%    

cash flow

                      -113 167 80.7 90.3 155    
                      -2.94 -17.3 -19.9 -15.1 -41.3    
                      0.000 0.000 0.000 0.000 0.000    
                      -116 150 60.8 75.2 114    

Download Data
income statement Unit
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Cost of Goods & Services CZK mil
Gross Profit CZK mil
Staff Cost CZK mil
Other Cost CZK mil
EBITDA CZK mil
Depreciation CZK mil
EBIT CZK mil
Financing Cost CZK mil
Extraordinary Cost CZK mil
Pre-Tax Profit CZK mil
Tax CZK mil
Minorities CZK mil
Net Profit CZK mil
Dividends CZK mil
                      3,962 3,930 4,056 4,686 5,393    
                      3,557 3,496 3,556 3,976 4,616    
                      405 435 500 710 776    
                      310 336 402 569 616    
                      33.0 28.5 27.3 28.0 29.8    
                      61.6 69.8 71.6 113 131    
                      4.96 5.86 9.18 15.3 19.8    
                      56.7 64.0 62.4 97.6 111    
                      5.49 14.0 10.2 8.33 5.81    
                      0.000 0.000 0.000 0.000 0.000    
                      51.2 50.0 52.3 89.2 105    
                      9.43 -4.07 3.93 7.01 22.3    
                      0.000 0.000 0.000 0.000 0.000    
                      41.7 50.0 52.3 82.2 82.7    
                      0.000 0.000 0.000 0.000 0.000    

growth rates

...                     4.72% -0.791% 3.20% 15.5% 15.1%    
...                     8.43% 6.24% 17.6% 39.1% 8.21%    
...                     3.11% 13.4% 2.54% 57.5% 15.7%    
...                     1.78% 12.9% -2.41% 56.3% 13.5%    
...                     -1.98% -2.34% 4.60% 70.8% 17.6%    
...                     0.860% 19.7% 4.60% 57.3% 0.548%    

ratios

                      19.2% 18.9% 16.5% 21.6% 17.8%    
...                     7.85% 8.64% 5.36% 7.06% 8.58%    
                      10.2% 11.1% 12.3% 15.1% 14.4%    
                      1.56% 1.78% 1.77% 2.41% 2.42%    
                      1.43% 1.63% 1.54% 2.08% 2.05%    
                      1.05% 1.27% 1.29% 1.75% 1.53%    
                      0.000% 0.000% 0.000% 0.000% 0.000%    
...                     2.97% 10.8% 36.9% 17.3% 12.1%    
                      3.22 0.696 -0.064 0.826 -0.015    

Download Data
balance sheet Unit
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

balance sheet

                      12.0 23.4 34.3 34.3 55.3    
                      12.0 23.4 34.3 34.3 55.3    
                      0.000 0.000 0.000 0.000 0.708    
                      1,383 1,487 1,469 1,611 1,853    
                      787 723 846 865 1,051    
                      590 757 1,459 743 799    
                      6.37 6.57 4.57 2.88 1.97    
                      1,401 1,514 1,507 1,646 1,911    
                      238 292 340 423 505    
                      0.000 0.000 0.000 0.000 0.000    
                      1,163 1,222 1,167 1,224 1,406    
                      0.000 0.000 0.000 0.000 0.000    
                      0.000 0.000 0.000 0.000 0.000    
                      0.000 0.000 0.000 0.000 0.000    
                      1,154 1,205 1,147 1,203 1,380    
                      205 55.2 0.000 96.0 0.000    
                      773 963 931 722 899    
                      8.56 11.9 13.4 18.6 25.9    
                      1,401 1,514 1,507 1,646 1,911    

growth rates

...                     12.2% 8.05% -0.432% 9.23% 16.1%    
...                     21.3% 22.7% 16.5% 24.2% 19.6%    
...                     141% -75.5% -109% -2,141% -102%    
...         ...           24.4% -73.0% -100% ... -100% ...  

ratios

                      205 55.2 0.000 96.0 0.000    
                      198 48.6 -4.57 93.2 -1.97    
                      604 517 1,375 886 951    
                      616 540 1,409 921 1,007    
                      83.3% 16.7% -1.34% 22.0% -0.390%    
...                     2.97% 10.8% 36.9% 17.3% 12.1%    

Download Data
cash flow Unit
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

cash flow

                      41.7 50.0 52.3 82.2 82.7    
                      4.96 5.86 9.18 15.3 19.8    
...                     11.5 23.5 877 -495 117    
...                     -172 87.7 -858 488 -64.9    
                      -113 167 80.7 90.3 155    
                      -3.06 -17.3 -20.2 -15.3 -41.6    
                      0.121 0.025 0.280 0.225 0.306    
                      -2.94 -17.3 -19.9 -15.1 -41.3    
                      0.000 0.000 0.000 0.000 0.000    
                      0.000 0.000 0.000 0.000 0.000    
...                     40.2 -150 -55.2 96.0 -96.0    
                      0.000 0.000 0.000 0.000 0.000    
                      -116 150 60.8 75.2 114    

ratios

                      54.4 70.3 131 57.9 54.1    
                      80.7 75.5 86.9 79.4 83.1    
                      79.3 101 95.5 66.3 71.1    
                      55.8 45.2 123 71.0 66.1    
                      46.7 55.8 61.4 97.5 102    
                      -116 150 60.8 75.2 114    

Download Data
other data Unit
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

other data

                      3.15% 3.43% 3.46% 5.22% 4.65%    
                      10.2% 11.1% 12.3% 15.1% 14.4%    
                      248 255 267 276 327    
                      5,894 5,617 6,405 8,034 6,576    
                      104,246 109,862 125,322 171,709 156,955    
                      7.94% 8.70% 10.1% 12.4% 11.7%    
                      18.4% -8.15% 7.52% 7.86% 21.2%    
... ... ... ... ... ... ... ... ... ... ... ... ... ... 3,035 3,486    
                      0.077% 0.440% 0.497% 0.327% 0.771%    
... ... ... ... ... ... ... ... ... ... ... ... ... ... 1,651 1,906    
... ... ... ... ... ... ... ... ... ... ... ... ... ... 35.2% 35.3%    

Download Data
Comparison of 9 Companies in Czech Pharmaceutical Companies

This Annual Statistical Dossier offers a comparison of 9 companies from Czech Pharmaceutical Companies from 2000 to 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

The file

Read more »

This Annual Statistical Dossier offers a comparison of 9 companies from Czech Pharmaceutical Companies from 2000 to 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

The file contains data of following companies:

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

Download a sample excel file attached to see more details. On purchase, the hidden cells will be unlocked and all available data wll be visible.

Novartis Czech Republic in Numbers

This Annual Statistical Dossier offers a summary of Novartis Czech Republic's performance between 2000 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only

Read more »

This Annual Statistical Dossier offers a summary of Novartis Czech Republic's performance between 2000 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

If you are interested in the company’s quarterly figures, please refer to the company’s Quarterly Statistical Dossier.

Novartis Czech Republic made a net profit of CZK CZK 71.0 mil under revenues of CZK 6,312 mil in 2017, down 6.08% and -1.25%, respectively, when compared to the last year.

This translates into a net margin of 1.12%. Historically,

Read more »

Novartis Czech Republic made a net profit of CZK CZK 71.0 mil under revenues of CZK 6,312 mil in 2017, down 6.08% and -1.25%, respectively, when compared to the last year.

This translates into a net margin of 1.12%. Historically, the firm’s net margin reached an all time high of 1.75% in 2014 and an all time low of 0.131% in 2000. The average net margin in the last five years amounted to 1.38%.

On the operating level, EBITDA margin reached 1.76% and EBIT amounted to 2.18% of sales in 2017.

You can see all the company’s data at Novartis Czech Republic Profile, or you can download a report on the company in the report section.

Novartis Czech Republic made a net profit of CZK 71.0 mil under revenues of CZK 6,312 mil in 2017, down -6.08% and -1.25%, respectively, when compared to the last year. This translates into a net margin of 1.12%.

Historically,

Read more »

Novartis Czech Republic made a net profit of CZK 71.0 mil under revenues of CZK 6,312 mil in 2017, down -6.08% and -1.25%, respectively, when compared to the last year. This translates into a net margin of 1.12%.

Historically, the firm’s net profit reached an all time high of CZK 82.7 mil in 2015 and an all time low of CZK 2.15 mil in 2000. Since 2012, the firm's net profit has increased 42.1% or 7.27% a year on average.

On the operating level, EBITDA reached CZK 138 mil, up -18.9% when compared to the previous year. Over the last five years, company's EBITDA has grown 14.6% a year on average.

You can see all the company’s data at Novartis Czech Republic Profile, or you can download a report on the company in the report section.

Novartis Czech Republic's net debt reached CZK 51.2 mil and accounted for 7.85% of equity at the end of 2017. The ratio is up 154% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all

Read more »

Novartis Czech Republic's net debt reached CZK 51.2 mil and accounted for 7.85% of equity at the end of 2017. The ratio is up 154% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 494% in 2002 and an all time low of -183% in 2004.

When compared to EBITDA, net debt amounted to 0.371x at the end of the year. The ratio reached an all time high of 12.8 in 2004 and an all time low of -38.0 in 2007.

You can see all the company’s data at Novartis Czech Republic Profile, or you can download a report on the company in the report section.

Novartis Czech Republic made a net profit of CZK 71.0 mil in 2017, down 6.08% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 82.7 mil in 2015 and an all time low of CZK 3.47 mil in 2001.

Read more »

Novartis Czech Republic made a net profit of CZK 71.0 mil in 2017, down 6.08% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 82.7 mil in 2015 and an all time low of CZK 3.47 mil in 2001.

This implies return on equity of 11.5% and return on invested capital of 5.67% in 2017. That is compared to 16.3% and 6.74% average seen in the last five years.

Since 2012, net profit of the firm increased by -34.4% or -8.10% a year on average.

You can see all the company’s data at Novartis Czech Republic Profile, or you can download a report on the company in the report section.

See all charts of the company »
Novartis Czech Republic's employees rose 48.3% to 743 in 2017
Novartis Czech Republic's net profit fell 6.08% to CZK 71.0 mil in 2017
Novartis Czech Republic's net profit fell 6.08% to CZK 71.0 mil in 2017
Novartis Czech Republic's Capital Expenditures fell 83.6% to CZK 16.9 mil in 2017
Novartis Czech Republic's Total Cash From Operations fell 126% to CZK -16.5 mil in 2017
Novartis Czech Republic's Cash & Cash Equivalents fell 100% to CZK 0.000 mil in 2017
Novartis Czech Republic's ROCE fell 19.6% to 5.67% in 2017
Novartis Czech Republic's Net Debt/EBITDA rose 251% to 0.371 in 2017
Novartis Czech Republic's Net Margin fell 4.89% to 1.12% in 2017